244 related articles for article (PubMed ID: 30638914)
21. Predictors of Occurrence and Risk of Hepatic Encephalopathy After TIPS Creation: A 15-Year Experience.
Coronado WM; Ju C; Bullen J; Kapoor B
Cardiovasc Intervent Radiol; 2020 Aug; 43(8):1156-1164. PubMed ID: 32435836
[TBL] [Abstract][Full Text] [Related]
22. Clearing the Confusion over Hepatic Encephalopathy After TIPS Creation: Incidence, Prognostic Factors, and Clinical Outcomes.
Casadaban LC; Parvinian A; Minocha J; Lakhoo J; Grant CW; Ray CE; Knuttinen MG; Bui JT; Gaba RC
Dig Dis Sci; 2015 Apr; 60(4):1059-66. PubMed ID: 25316553
[TBL] [Abstract][Full Text] [Related]
23. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
Saad WE; Darwish WM; Davies MG; Waldman DL
J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
[TBL] [Abstract][Full Text] [Related]
24. Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy: Sarcopenia Adds Insult to Injury.
Bhatia Kapoor P; Benjamin J; Tripathi H; Patidar Y; Maiwall R; Kumar G; Joshi YK; Sarin SK
Turk J Gastroenterol; 2023 Apr; 34(4):406-412. PubMed ID: 36620928
[TBL] [Abstract][Full Text] [Related]
25. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests.
Berlioux P; Robic MA; Poirson H; Métivier S; Otal P; Barret C; Lopez F; Péron JM; Vinel JP; Bureau C
Hepatology; 2014 Feb; 59(2):622-9. PubMed ID: 24620380
[TBL] [Abstract][Full Text] [Related]
26. Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement.
Nardelli S; Lattanzi B; Torrisi S; Greco F; Farcomeni A; Gioia S; Merli M; Riggio O
Clin Gastroenterol Hepatol; 2017 Jun; 15(6):934-936. PubMed ID: 27816756
[TBL] [Abstract][Full Text] [Related]
27. Critical flicker frequency as a marker of hepatic encephalopathy in patients before and after transjugular intrahepatic portosystemic shunt.
Biecker E; Hausdörfer I; Grünhage F; Strunk H; Sauerbruch T
Digestion; 2011; 83(1-2):24-31. PubMed ID: 20847560
[TBL] [Abstract][Full Text] [Related]
28. Refractory Hepatic Encephalopathy After Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors and Outcomes with Revision.
Rowley MW; Choi M; Chen S; Hirsch K; Seetharam AB
Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1765-1772. PubMed ID: 29872892
[TBL] [Abstract][Full Text] [Related]
29. Pathological Predictors of Shunt Stenosis and Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt.
He F; Dai S; Xiao Z; Wang L; Yue Z; Zhao H; Zhao M; Lin Q; Dong X; Liu F
Biomed Res Int; 2016; 2016():3681731. PubMed ID: 27975051
[No Abstract] [Full Text] [Related]
30. Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt.
Yin L; Chu SL; Lv WF; Zhou CZ; Liu KC; Zhu YJ; Zhang WY; Wang CX; Zhang YH; Lu D; Cheng DL
World J Gastroenterol; 2023 May; 29(18):2875-2887. PubMed ID: 37274064
[TBL] [Abstract][Full Text] [Related]
31. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
Teng D; Zuo H; Liu L; Dong J; Ding L
Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
[TBL] [Abstract][Full Text] [Related]
32. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation.
Charon JP; Alaeddin FH; Pimpalwar SA; Fay DM; Olliff SP; Jackson RW; Edwards RD; Robertson IR; Rose JD; Moss JG
J Vasc Interv Radiol; 2004 Nov; 15(11):1219-30. PubMed ID: 15525740
[TBL] [Abstract][Full Text] [Related]
33. Transjugular Portosystemic Shunt Reductions: A Retrospective Single-Center Experience.
Joseph AS; Sandhu B; Khalil A; Lopera J
J Vasc Interv Radiol; 2019 Jun; 30(6):876-884. PubMed ID: 31126600
[TBL] [Abstract][Full Text] [Related]
34. Proton Pump Inhibitor Therapy and Hepatic Encephalopathy Risk in Cirrhotic Patients: A Systematic Review with Meta-analysis.
Shi D; Zhou Z; Dai Y; Pan X; Cao Q
Clin Drug Investig; 2019 Sep; 39(9):847-856. PubMed ID: 31183628
[TBL] [Abstract][Full Text] [Related]
35. Transjugular Intrahepatic Portosystemic Shunt Creation and Variceal Coil or Plug Embolization Ineffectively Attain Gastric Variceal Decompression or Occlusion: Results of a 26-Patient Retrospective Study.
Lakhoo J; Bui JT; Lokken RP; Ray CE; Gaba RC
J Vasc Interv Radiol; 2016 Jul; 27(7):1001-11. PubMed ID: 27106732
[TBL] [Abstract][Full Text] [Related]
36. The combination of Child-Pugh score and quantitative CT-based spleen volume could predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation.
Liu J; Zhou C; Wang Y; Yang C; Shi Q; Huang S; Chen Y; Li T; Xiong B
Abdom Radiol (NY); 2021 Jul; 46(7):3464-3470. PubMed ID: 33660042
[TBL] [Abstract][Full Text] [Related]
37. Psoas Muscle Density Predicts Occurrences of Hepatic Encephalopathy in Patients Receiving Transjugular Intrahepatic Portosystemic Shunts within 1 year.
Cai W; Lin H; Qi R; Lin X; Zhao Y; Chen W; Huang Z
Cardiovasc Intervent Radiol; 2022 Jan; 45(1):93-101. PubMed ID: 34523022
[TBL] [Abstract][Full Text] [Related]
38. Prediction of Mortality and Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Placement: Baseline and Longitudinal Body Composition Measurement.
Tuifua TS; Kapoor B; Partovi S; Shah SN; Bullen JA; Enders J; Laique S; Levitin A; Gadani S
J Vasc Interv Radiol; 2024 May; 35(5):648-657.e1. PubMed ID: 38244917
[TBL] [Abstract][Full Text] [Related]
39. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
Tsai CF; Chen MH; Wang YP; Chu CJ; Huang YH; Lin HC; Hou MC; Lee FY; Su TP; Lu CL
Gastroenterology; 2017 Jan; 152(1):134-141. PubMed ID: 27639806
[TBL] [Abstract][Full Text] [Related]
40. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
